# Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

> **NCT01471821** · PHASE4 · COMPLETED · sponsor: **Juan A. Arnaiz** · enrollment: 250 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** antiretroviral treatment

## Key facts

- **NCT ID:** NCT01471821
- **Lead sponsor:** Juan A. Arnaiz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2014-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01471821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01471821, "Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01471821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*